Titans Face Uncertain Timeline With McCoy As Medical Red Flags Mount Ahead of Draft

The Tennessee Titans have a significant problem on their hands, and it has nothing to do with the on field performance of their cornerback prospect Jermod McCoy. The problem is that McCoy, who was viewed as a potential mid round selection for the franchise, may not be the long term defensive back solution they hoped to acquire when they began evaluating him. Fresh medical concerns surrounding his right knee suggest that his recovery trajectory from a torn ACL may be far more complicated than initial assessments indicated when he underwent surgery following last season.

This situation illustrates a broader reality in modern NFL scouting and roster construction that many teams still refuse to fully acknowledge. Injuries do not exist in isolation. They have compounding effects. They create uncertainty. They demand flexibility in planning. For a Titans organization that has already invested significant capital and patience in their defensive reconstruction, the emergence of these new medical complications represents exactly the kind of variable that can derail draft strategy and long term planning.

McCoy missed the entire 2024 season after tearing his ACL, which is already a massive red flag for a player trying to establish himself at an elite position that demands explosive lateral movement and instantaneous directional changes. The cornerback position is arguably the most physically demanding defensive position in football aside from pass rusher. A cornerback needs to accelerate, decelerate, plant and cut almost instantaneously. These are the exact movements that stress a recovering ACL. The fact that McCoy has now apparently suffered a setback significant enough to warrant another surgical procedure raises serious questions about the quality of his rehabilitation or, more troublingly, the structural integrity of his knee after the initial injury.

Let's be direct about what this means. When a player requires a second surgery on the same knee within a relatively short recovery window, it typically indicates one of several scenarios. Either the initial surgical repair was incomplete or improperly executed. Or the rehabilitation did not progress as anticipated. Or most concerning of all, the injury was more severe than initial diagnostics revealed. None of these scenarios are particularly encouraging when you are evaluating a player who depends upon lower body explosiveness to succeed at his position.

The Titans have significant defensive needs heading into the offseason. Their secondary has been a consistent source of vulnerability. Their cornerback room lacks established performers capable of providing shutdown coverage at the boundary. McCoy was potentially an option to address this deficiency if his medical evaluation cleared. But the emergence of these complications changes the entire calculus. The team cannot simply ignore warning signs and hope for the best. That approach has failed too many times across the NFL.

Here is where the business and legal side of this situation becomes critical. If the Titans do select McCoy in the draft with the knowledge that he may require additional surgery, they inherit significant contractual and cap related risks. Under the current collective bargaining agreement, teams cannot recoup signing bonuses if a player is placed on injured reserve during his rookie contract. If McCoy has another setback after being drafted, the Titans could find themselves holding a dead cap hit that cannot be removed except through injury waivers or termination. This creates a scenario where the team has spent draft capital on a player who cannot contribute while still bearing the financial burden of his contract.

The counterpoint that some will raise is that this situation presents opportunity. If McCoy's medical issues are being overblown or if his recovery is truly on track despite the need for follow up surgery, then selecting him in the later rounds could yield tremendous value. A cornerback with his physical tools and pedigree from a major college program should not be available in the fifth or sixth round if he were healthy. But that is precisely why this situation demands exceptional caution. The discount that McCoy is receiving on the draft board exists for a specific reason. That reason is medical uncertainty.

There is also the question of what these medical complications say about the University of Tennessee's medical staff and facilities. The Volunteers have strong incentives to ensure that McCoy recovers properly because his professional success reflects positively on their program. If even their resources were insufficient to prevent a setback, that suggests the injury was truly severe. This is not a criticism of Tennessee's medical department. Rather, it is an acknowledgment that some injuries are simply more complicated than initial assessments suggest.

The Titans need to approach this situation with clear eyes and realistic timelines. If McCoy requires another surgery, he is unlikely to be available at the start of training camp. He will almost certainly miss significant time during the offseason program and potentially the preseason. This means the team would be investing draft capital in a player who cannot contribute during the most critical development period of his professional career. For a rookie cornerback, this is particularly problematic because the preseason is essential for acclimating to NFL spacing, footwork adjustments, and the speed of the game at the professional level.

The CBA implications here are worth exploring further. Teams receive injury exemptions for roster spots during the preseason, but these exemptions are temporary. A player on the physically unable to perform list can only remain there for so long before the team must either activate him, place him on injured reserve, or release him. If McCoy is still recovering when these windows close, the Titans could face a difficult decision about his roster status before he has had any meaningful opportunity to contribute.

From a purely strategic standpoint, the Titans would be better served by addressing their cornerback needs through free agency or by selecting a player who is medically cleared rather than gambling on McCoy's continued recovery. Yes, free agent cornerbacks at the level the Titans need are expensive. But the guaranteed money involved in a free agent contract is at least predictable. The money tied up in McCoy's rookie deal would be completely wasted if his knee complications prevent him from playing.

The broader lesson here is that medical information is not static. Injuries evolve. Recovery does not always progress linearly. The responsible approach to draft evaluation demands that teams constantly update their assessments based on new information rather than committing to players based on outdated or incomplete medical data. If McCoy is indeed facing another surgery, the Titans should heavily discount his draft value accordingly and seriously consider whether his situation represents the kind of risk that is worth taking at a position where they could find alternatives without the medical baggage.

This is not a criticism of McCoy as a person or player. It is simply an acknowledgment of medical reality and the business principles that should govern draft decision making. The Titans would be wise to pump the brakes and wait for clarity before committing valuable resources to his situation.